Back to CGEM
MPM BioImpact LLC CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$149.2M
Q3 2026
Peak value
$177.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $79.2M |
| Q1 2026 | $108.7M |
| Q2 2026 | $177.2M |
| Q3 2026 | $149.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $149.2M | 9.72M | — | — |
| Q2 2026 | $177.2M | 9.73M | — | — |
| Q1 2026 | $108.7M | 7.65M | — | — |
| Q4 2025 | $79.2M | 7.65M | — | — |
Other funds holding CGEM
$163.2M
$163.2M
$137.6M
$127.4M
$104.7M
$88.3M
$81.7M